Lisa J. Wood - Concepedia

Author

Lisa J. Wood

Oregon Health & Science University ORCID

Also Known As

A Wood, D. Walsh, L J Wood, L Wood, L. Wood, L.J. Wood, Lisa J Wood, Lisa J Wood Magee, Lisa J. Wood, Lisa J. Wood Magee

Publications

4.4K

Citations

H-Index

119

Concepts

All Affiliations

Oregon Health & Science University MGH Institute of Health Professions Johns Hopkins University Johns Hopkins Medicine University of Edinburgh

About

Lisa J. Wood is an author at Oregon Health & Science University specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	22	1.2K
2	Health Sciences	3	3	66
3	Natural Sciences	2	2	245
4	Nursing	1	1	10
5	Applied Physiology	1	1	10

Lisa J. Wood

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial Martin Dennis, Gillian Mead, John Forbes, The Lancet	2018	276
CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms Jeffrey Tyner, Thomas G.P. Bumm, Jutta Deininger, Blood	2010	236
Kinase Domain Mutants of Bcr-Abl Exhibit Altered Transformation Potency, Kinase Activity, and Substrate Utilization, Irrespective of Sensitivity to Imatinib Ian J. Griswold, Mary MacPartlin, Thomas G.P. Bumm, Molecular and Cellular Biology Imatinib ResistanceSignal TransductionImatinib BindingKinase Domain MutantsCell Regulation	2006	198
Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease Thomas G.P. Bumm, Collin Elsea, Amie S. Corbin, Cancer Research	2006	193
Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome Kristin A. Sauter, Lisa J. Wood, John Wong, Cancer Biology & Therapy	2011	192
Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial Philip M. Bath, Polly Scutt, Craig S. Anderson, The Lancet	2019	192
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock, The Lancet	2019	188
<i>HMG-I/Y</i>, a New c-Myc Target Gene and Potential Oncogene Lisa J. Wood, Mita Mukherjee, Christine Dolde, Molecular and Cellular Biology	2000	173
The oncogenic properties of the HMG-I gene family. Lisa J. Wood, Joseph F. Maher, Tracie E. Bunton, PubMed Architectural Chromatin-binding ProteinsTumor BiologyChromatinCell RegulationMedicine	2000	165
HMGA2 Participates in Transformation in Human Lung Cancer Francescopaolo Di Cello, Jöelle Hillion, Alexandra C. Hristov, Molecular Cancer Research	2008	131

Page 1